Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target - sprookjes - yvandenbroek - TriplyDB

Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target

Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target

http://www.wikidata.org/entity/Q28750209

about

sameAs

Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics Modulation of GITR for cancer immunotherapy Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.An update on the use of NOD mice to study autoimmune (Type 1) diabetes.Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system.TNF superfamily in inflammatory disease: translating basic insights.Th2 responses to helminth parasites can be therapeutically enhanced by, but are not dependent upon, GITR-GITR ligand costimulation in vivo.Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.MicroRNA and mRNA Transcriptome Profiling in Primary Human Astrocytes Infected with Borrelia burgdorferi Correlation of increased blood levels of GITR and GITRL with disease severity in patients with primary Sjögren's syndrome Alterations of peripheral CD4+CD25+Foxp3+ T regulatory cells in mice with STZ-induced diabetes.Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy.Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model.

P2860

Q26823789-2A3C87EB-CCE3-4B0C-8B14-9DD35363B98E Q26853557-ABB9D2B0-CCA0-42B6-844E-B625CE6F4A8C Q34450476-524E3DCB-27C2-40B9-AD4A-93DABBE92FC0 Q34508281-DB312788-B54F-42CB-B253-926B5C0708DD Q35608087-5AEE886D-442F-4472-9A24-1C4980DFCF29 Q35821666-8E646256-7D89-4247-AD52-57C31FCEDD23 Q36124241-A6D61C6C-0FA6-4D00-BB0B-56095482730D Q36147260-50B8A536-E28B-4ED2-8457-17B80539AD3F Q36263876-7D893EAF-ACED-4D18-A628-1DEDC93F4B25 Q37043989-070D609F-4CA2-4EC3-A60F-1808913AC1B3 Q37729140-A6A73752-16E9-4535-BC6A-65B6D873102B Q37799255-5C83B362-EE75-4252-B91D-C4DF01E7206F Q37948129-D916774D-2237-4C04-9AA3-68E4A07A5EF7 Q38999162-25048932-D4C1-4141-8B41-F7FEBF28504F Q42099442-FCBE8566-85B8-4FA1-91C1-19F53B674934 Q47138569-561E7824-5256-4632-881B-75C7D4DD325B

P2860

Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target

http://www.wikidata.org/entity/Q28750209

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Key role of the GITR/GITRLigan ...... a potential therapeutic target

@ast

Key role of the GITR/GITRLigan ...... a potential therapeutic target

@en

Key role of the GITR/GITRLigan ...... a potential therapeutic target

@nl

type

label

Key role of the GITR/GITRLigan ...... a potential therapeutic target

@ast

Key role of the GITR/GITRLigan ...... a potential therapeutic target

@en

Key role of the GITR/GITRLigan ...... a potential therapeutic target

@nl

prefLabel

Key role of the GITR/GITRLigan ...... a potential therapeutic target

@ast

Key role of the GITR/GITRLigan ...... a potential therapeutic target

@en

Key role of the GITR/GITRLigan ...... a potential therapeutic target

@nl

P1433

Q28750209-03AAA66E-D900-4BA2-B289-C3717242DD09

P1476

Q28750209-78AA654D-5082-4643-A53E-1D8635A4DBE2

P2093

Q28750209-23C0BF58-547A-41C9-8B53-D07BC1202541

Q28750209-27501E7E-7E35-455A-9382-DE9DFF729A4F

Q28750209-2CECEBAF-A47D-4594-B719-0850FC6DA5D3

Q28750209-59F393A0-A503-40DA-A39C-3D1CADE30337

Q28750209-90DE9568-1F3B-4EFF-961F-0A34FCB51818

Q28750209-D62F835F-272D-40FE-AC06-A995F55A0283

P2860

Q28750209-00889376-38A1-4744-A5DF-4ED004C7B34A

Q28750209-0101AE03-062A-485F-8B4B-62D62681E22C

Q28750209-058F0422-D594-4E76-9F29-705334CDC526

Q28750209-0835D588-F325-439E-84A0-B319349C2382

Q28750209-0BB15453-BCD7-4570-B705-7BF956BAF73A

Q28750209-1EB1A797-2D2A-43DE-B54E-4F2A0F2C5E6A

Q28750209-1F2DB425-B43A-4FBB-A838-1795F562B4FF

Q28750209-22F6187B-CC7B-437A-A3D1-A8FBAB81C752

Q28750209-23AA51F4-F0E2-47D4-8403-38F406CF9F57

Q28750209-2DF2D060-C873-44B9-9AC8-C46D14EEE055

P304

Q28750209-E1DC04F0-791E-47EE-AF32-AC3371C768CB

P31

Q28750209-4CB45675-6668-4403-835C-090ABCE97A75

P356

Q28750209-ADA1036D-84C8-42A4-B2AC-2989F344B4B8

P407

Q28750209-C575D1F6-AD3C-4397-9CA7-F9BC15C36457

P433

Q28750209-59299555-57C7-4279-A564-C55F81F345D1

P478

Q28750209-C6D1AD3F-E1C2-4AC8-81EC-17D64653F8F7

P50

Q28750209-2FC64FBE-F674-426E-8D14-F78F9DC24B2F

Q28750209-5E670DB4-ABFF-43F7-98C0-5CEE10414407

Q28750209-75FF57C0-9E3C-4EA6-B322-FC41FCD91AD2

Q28750209-BCE01851-BEA7-485D-A607-384F67012F3E

Q28750209-EF007E53-6D55-4426-BAF8-1ED0300917D4

P577

Q28750209-6B14A04B-477E-468B-BF7A-3ED7292611D4

P5875

Q28750209-6A25AF09-4010-4E22-AEA0-29004AB80835

P698

Q28750209-6A1E1EDC-9CC9-4D6E-9FA3-F2B352A770DF

P932

Q28750209-4AE4C801-9816-4782-9599-6D293318EA3F

P356

JOURNAL.PONE.0007848

P1433

P1476

Key role of the GITR/GITRLigan ...... a potential therapeutic target

@en

P2093

Berta Segovia

http://www.w3.org/2001/XMLSchema#string

Chih-Pin Liu

http://www.w3.org/2001/XMLSchema#string

Douglas Ringler

http://www.w3.org/2001/XMLSchema#string

Lynn Poulton

http://www.w3.org/2001/XMLSchema#string

Michael Rosenzweig

http://www.w3.org/2001/XMLSchema#string

Wen-Hui Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

Breeding of a non-obese, diabetic strain of mice

Cloning and characterization of GITR ligand

Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells

The effect of infections on susceptibility to autoimmune and allergic diseases

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.

P304

e7848

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0007848

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Lucienne Chatenoud

Jean-François Bach

Stephen P. Cobbold

Herman Waldmann

P577

2009-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40029541

http://www.w3.org/2001/XMLSchema#string

P698

19936238

http://www.w3.org/2001/XMLSchema#string

P932

2775640

http://www.w3.org/2001/XMLSchema#string